Pembrolizumab for Early Triple-Negative Breast CancerPeter Schmid, Joyce O’Shaughnessy, Rina Hui et al.|New England Journal of Medicine|2020Cited by 3.1k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, David Cameron, William Jacot et al.|New England Journal of Medicine|2022Cited by 2.5k
Gene Expression Profiling of Breast Cancer Brain MetastasisJi Yun Lee, Yeon Hee Park|Scientific Reports|2016Cited by 76
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerChanghwan Sung, Sook Ryun Park, Jinhyeon An et al.|Nature Cancer|2023Cited by 46